Skip to main content

Vulvar Lichen Sclerosus

Pathophysiology and Treatment

American Journal of Clinical Dermatology volume 5, pages 105–125 (2004)Cite this article

Abstract

Lichen sclerosus is a chronic disorder of the skin and mucosal surfaces, and is most commonly seen on the female genital skin. It also occurs on other areas of the body. Any age group may be affected, although it is seen more often in elderly women. The exact cause of lichen sclerosus is unknown. There have been reports of family members with lichen sclerosus; thus it may have a genetic link. There is also the possibility of an autoimmune connection. Currently, ultra-potent topical corticosteroids are the medical treatment of choice. Other treatments that have been utilized for this condition include testosterone, progesterone, tacrolimus, surgery, and phototherapy. Surgery should be reserved for symptomatic patients who fail to respond to multiple medical treatments, as there is a high recurrence rate following surgery. The risk of developing squamous cell carcinoma of the vulva approaches 5% in women with vulvar lichen sclerosus, and therefore close surveillance by the healthcare provider and patient is needed. This review discusses the history, clinical features, pathophysiology, and treatment of lichen sclerosus of the vulva, as well as pregnancy issues and sexual function in patients with this condition. In addition, problems specific to children with lichen sclerosus are reviewed.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 49.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Table I
Table II
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Table III
Table IV
Fig. 9
Fig. 10.
Table V
Table VI
Table VII
Table VIII
Table IX

Notes

  1. The use of trade names is for product identification purposes only and does not imply endorsement.

References

  1. Hallopeau H. Du Lichen plan, et particulièrement de sa forme atrophique. Un Méd (Par) 1887; 43: 729–33

    Google Scholar 

  2. Weir RF. Icthyosis of the tongue and vulva. NY State J Med 1875: 246

    Google Scholar 

  3. Darier J. Lichen plan sclereux. Ann Dermatol Syph 1892; 3: 833–7

    Google Scholar 

  4. Friedrich EG. Lichen sclerosus. J Reprod Med 1976; 17: 147–54

    PubMed  Google Scholar 

  5. Meffert JJ, Davis BM, Grimwood RE. Lichen sclerosus. J Am Acad Dermatol 1995; 32: 393–416

    Article  PubMed  CAS  Google Scholar 

  6. Tait SR. Serpiginous vascular degeneration of the nymphae. In: Tait RL. Diseases of Women. New York. William Wood & Co., 1877: 43–7

    Google Scholar 

  7. Breisky A. Ueber kraurosis vulvae, eine wenig beachtete Form von Hautatrophie an Pudendum muliebre. Ztschr f Heilk 1885; 6: 69–80

    Google Scholar 

  8. Unna PG. Karenblattförmige sklerodermie: lehrbuch der speziell path anatomie (8 lief). Berlin: A Hirschwald, 1894

    Google Scholar 

  9. Johnstone AW. Trachoma of the female genito-urinary tract. Tr Am Gynec Soc (Phila) 1895; 20: 427–34

    Google Scholar 

  10. Johnstone AW. Trachoma of the female genito-urinary tract. Am Gynaec Obstet J N Y 1895; 6: 764–9

    Google Scholar 

  11. Pichevin R, Pettit A. Leucoplasie vulvóvaginale. Semaine Gynéc Par 1897; 2: 257, 265, 276, 284

    Google Scholar 

  12. Westberg F. Ein Fall von mit weissen Flecken einhergehender, bisher nicht bekannter Dermatose. Monatschr Prakt Dermatol 1901; 33: 355–61

    Google Scholar 

  13. von Zumbusch LR. Über Lichen albus, eine bisher unbeschriebene Erkrankung. Arch Dermatol Syph (Berlin) 1906; 82: 339–50

    Google Scholar 

  14. Montgomery FH, Ormsby O. “White spot disease” (morphea guttata) and lichen planus sclerosus et atrophicus: a clinical and histological study of three cases, with a review of the literature. J Cutan Dis 1907; 25: 1–16

    Google Scholar 

  15. Csillag J. Dermatitis lichenoides chronica atrophicans [abstract]. Ikonographia Dermatol 1909; 4: 147

    Google Scholar 

  16. Veit J. Kraurosis vulvae (Leukoplakia vulvae). Handbuch der Gynakologie. 2nd ed. 1910; 4: 611–27

    Google Scholar 

  17. Berkeley C, Bonney V. Leucoplakic vulvitis and its relation to kraurosis vulvae and carcinoma vulvae. BMJ 1909; 2: 1739–44

    Article  PubMed  CAS  Google Scholar 

  18. Graves WP. Kraurosis vulvae: gynecology. 4th ed. Philadelphia (PA): WB Saunders Co., 1928

    Google Scholar 

  19. Ormsby OS, Mitchell J. Lichen planus atrophicus et sclerosus and kraurosis vulvae. Arch Derm Syph 1922; 5: 786

    Google Scholar 

  20. Taussig FJ. Precancerous lesions of the skin of the vulva. Arch Dermatol Syph 1920; 38: 621–35

    Google Scholar 

  21. Kyrle J. Histo-biologie der menschichen haut und ihrer erkrankungen. Wien: Verlag von Julius Springer, 1927

    Book  Google Scholar 

  22. Kogoj FR. Lichen sclerosus (atrophicus) primitivus [paper]. Arch Derm Syph 1934; 169: 465

    Google Scholar 

  23. Kogoj FR. Ueber die Stellung des Lichen sclerosus im System [abstract]. Arch Derm Syph 1936; 173: 615–23

    Google Scholar 

  24. Swift BH. Achlorhydria as an aetiological factor in pruritis vulvae associated with kraurosis or leucoplakia. J Obstet Gynecol Br Emp 1936; 43: 1053–77

    Google Scholar 

  25. Cinberg BL. Postmenopausal pruritis vulvae. Am J Obstet Gynecol 1945; 49: 647–57

    Google Scholar 

  26. Oberfield RA. Lichen sclerosus et atrophicus and kraurosis vulvae. Arch Dermatol 1961; 83: 806–15

    Article  PubMed  CAS  Google Scholar 

  27. Barker LP, Gross P. Lichen sclerosus et atrophicus of the female genitalia. Arch Dermatol 1962; 85: 362–73

    Article  PubMed  CAS  Google Scholar 

  28. Jeffcoate TN. Chronic vulval dystrophies. Am J Obstet Gynecol 1966; 95: 61–74

    PubMed  CAS  Google Scholar 

  29. Wallace HJ. Lichen sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc 1971; 57: 9–30

    PubMed  CAS  Google Scholar 

  30. Friedrich EG. New nomenclature for vulvar disease. Obstet Gynecol 1976; 47: 122–4

    Google Scholar 

  31. Jasionowski EA, Jasionowski P. Topical progesterone in treatment of vulvar dystrophy. Am J Obstet Gynecol 1977; 127: 667–70

    PubMed  CAS  Google Scholar 

  32. Jasionowski EA, Jasionowski PA. Further observations on the effect of topical progesterone on vulvar disease. Am J Obstet Gynecol 1979; 134: 565–7

    PubMed  CAS  Google Scholar 

  33. Laude TA, Narayanaswamy G, Rajkumar S. Lichen sclerosus et atrophicus in an eleven year old girl. Report of a case. Cutis 1980; 26: 78–80

    PubMed  CAS  Google Scholar 

  34. Harrington CI, Dunsmore IR. An investigation into the incidence of auto-immune disorders in patients with lichen sclerosus et atrophicus. Br J Dermatol 1981; 104: 563–6

    Article  PubMed  CAS  Google Scholar 

  35. Neuhofer J, Fritsch P. Treatment of localized scleroderma and lichen sclerosus with etretinate. Acta Derm Venereol (Stockh) 1984; 64: 171–4

    CAS  Google Scholar 

  36. Asbrink E, Hovmark A. Cutaneous manifestations in Ixodes-borne Borellia spirochetosis. Int J Dermatol 1987; 26: 215–23

    Article  PubMed  CAS  Google Scholar 

  37. Tuffanelli D. Do some patients with morphea and lichen sclerosus et atrophicans have a Borrelia infection? Am J Dermatopathol 1987; 9: 371–3

    Article  PubMed  CAS  Google Scholar 

  38. Clark JA, Muller S. Lichen sclerosus et atrophicus in children. Arch Dermatol 1967; 95: 476–82

    Article  PubMed  CAS  Google Scholar 

  39. Taussig FJ. Chronic leukoplakic vulvitis followed by cancer. Surg Clin North Am 1922; 2: 1559–70

    Google Scholar 

  40. Friedrich EG. Vulvar disease. Philadelphia (PA): WB Saunders, 1983

    Google Scholar 

  41. Bousema MT, Romppanen U, Geiger J, et al. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. J Am Acad Dermatol 1994; 30: 225–31

    Article  PubMed  CAS  Google Scholar 

  42. Thomas RH, Ridley CM, McGibbon DH, et al. Anogenital lichen sclerosus in women. J R Soc Med 1996; 89: 694–8

    PubMed  CAS  Google Scholar 

  43. Lorenz B, Kaufman RH, Kutzner SK. Lichen sclerosus: therapy with clobetasol propionate. J Reprod Med 1998; 9: 790–4

    Google Scholar 

  44. Ox2019Keefe RJ, Scurry JP, Dennerstein G, et al. Audit of 114 non-neoplastic vulvar biopsies. Br J Obstet Gynaecol 1995; 102: 780–6

    Article  PubMed  Google Scholar 

  45. Ball SB, Wojnarowska F. Vulvar dermatoses: lichen sclerosus, lichen planus, and vulvar dermatitis/lichen simplex chronicus. Semin Cutan Med Surg 1998; 17: 182–8

    Article  PubMed  CAS  Google Scholar 

  46. Rodke G, Friedrich Jr EG, Wilkinson EJ. Malignant potential of mixed vulvar dystrophy lichen sclerosus associated with squamous cell hyperplasia. J Reprod Med 1988; 33: 545–50

    PubMed  CAS  Google Scholar 

  47. Carlson JA, Lamb P, Malfetano J, et al. Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases. Mod Pathol 1998; 11: 844–54

    PubMed  CAS  Google Scholar 

  48. Marren P, Wojnarowska F, Powell S. Allergic contact dermatitis and vulvar dermatoses. Br J Dermatol 1992; 126: 52–6

    Article  PubMed  CAS  Google Scholar 

  49. Fung MA, LeBoit PE. Light microscopic criteria for the diagnosis of early vulvar lichen sclerosus: a comparison with lichen planus. Am J Surg Pathol 1998; 22: 473–8

    Article  PubMed  CAS  Google Scholar 

  50. Goolamali SK, Barnes EW, Irvine WJ, et al. Organ specific antibodies in patients with lichen sclerosus. BMJ 1974; 4: 78–9

    Article  PubMed  CAS  Google Scholar 

  51. Meyrick Thomas RH, Ridley CM, McGibbon DH, et al. Lichen sclerosus et atrophicus and autoimmunity: a study of 350 women. Br J Dermatol 1988; 118: 41–6

    Article  PubMed  CAS  Google Scholar 

  52. Meyrick Thomas RH, Ridley CM, Black MMK. The association of lichen sclerosus et atrophicus and autoimmune-related diseases in males. Br J Dermatol 1983; 109: 661–4

    Article  PubMed  CAS  Google Scholar 

  53. Lipscombe TK, Wayte J, Wojnarowska F, et al. A study of clinical and aetiological factors and possible associations of lichen sclerosus in males. Australas J Dermatol 1997; 38: 132–6

    Article  PubMed  CAS  Google Scholar 

  54. Sahn EE, Bluestein EL, Oliva S. Familial lichen sclerosus et atrophicus in childhood. Pediatr Dermatol 1994; 11: 160–3

    Article  PubMed  CAS  Google Scholar 

  55. Meyrick Thomas RH, Kennedy CT. The development of lichen sclerosus et atrophicus in monozygotic twin girls. Br J Dermatol 1986; 114: 377–9

    Article  PubMed  CAS  Google Scholar 

  56. Cox NH, Mitchell JN, Morley WN. Lichen sclerosus et atrophicus in non-identical female twins. Br J Dermatol 1986; 115: 743–6

    Article  PubMed  CAS  Google Scholar 

  57. Shirer Jr JA, Ray MC. Familial occurrence of lichen sclerosus et atrophicus. Arch Dermatol 1987; 123: 485–8

    Article  PubMed  Google Scholar 

  58. Murphy FR, Lipa M, Haberman HF. Familial vulvar dystrophy of lichen sclerosus type. Arch Dermatol 1982; 118: 329–31

    Article  PubMed  CAS  Google Scholar 

  59. Powell J, Wojnarowksa F, Winsey S, et al. Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol 2000; 142: 481–4

    Article  PubMed  CAS  Google Scholar 

  60. Marren P, Yell J, Charnock FM, et al. The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol 1995; 132: 197–203

    Article  PubMed  CAS  Google Scholar 

  61. Azurdia RM, Luzzi GA, Byren I, et al. Lichen sclerosus in adult men: a study of HLA associations and susceptibility to autoimmune disease. Br J Dermatol 1999; 140: 79–83

    Article  PubMed  CAS  Google Scholar 

  62. Farrell AM, Marren PM, Wojnarowska F. Genital lichen sclerosus associated with morphoea or systemic sclerosis: clinical and HLA characteristics. Br J Dermatol 2000; 143: 598–603

    Article  PubMed  CAS  Google Scholar 

  63. Meyrick Thomas RH, Ridley CM, Sherwood F, et al. The lack of association of lichen sclerosus et atrophicus with HLA-A and B tissue antigens. Clin Exp Dermatol 1984; 9: 290–2

    Article  PubMed  CAS  Google Scholar 

  64. Schwartz BD. The major histocompatibility complex and disease susceptibility. In: Wyngaarden JB, Smith Jr LH, Bennett JC, editors. Cecil textbook of medicine. Philadelphia (PA): Saunders, 1992: 1470–9

    Google Scholar 

  65. Dinarello CA, Thompson RC. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 1991; 12: 404–10

    Article  PubMed  CAS  Google Scholar 

  66. Clay FE, Cork MJ, Tarlow JK, et al. Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus. Hum Genet 1994; 94: 407–10

    Article  PubMed  CAS  Google Scholar 

  67. Betti R, Lodi A, Marmini A, et al. T cell peripheral subsets in lichen sclerosus et atrophicus. Br J Dermatol 1986; 11: 569–73

    CAS  Google Scholar 

  68. Carli P, Bracco G, Taddei G, et al. Vulvar lichen sclerosus immunohistologic evaluation before and after therapy. J Reprod Med 1994; 39: 110–4

    PubMed  CAS  Google Scholar 

  69. Farrell AM, Marren P, Dean D, et al. Lichen sclerosus: evidence that immunological changes occur at all levels of the skin. Br J Dermatol 1999; 140: 1087–92

    Article  PubMed  CAS  Google Scholar 

  70. Carlson JA, Grabowski R, Chichester P, et al. Comparative immunophenotypic study of lichen sclerosus: epidermotropic CD57+ lymphocytes are numerous: implications for pathogenesis. Am J Dermatopathol 2000; 22: 7–16

    Article  PubMed  CAS  Google Scholar 

  71. Gross T, Wagner A, Ugurel S, et al. Identification of TIA-1+ and granzyme B+ cytotoxic T cells in lichen sclerosus et atrophicus. Dermatol 2001; 202: 198–202

    Article  CAS  Google Scholar 

  72. Scrimin F, Rustja S, Radilo O, et al. Vulvar lichen sclerosus: an immunologic study. Obstet Gynecol 2000; 95: 147–50

    Article  PubMed  CAS  Google Scholar 

  73. Farrell AM, Dean D, Charnock M, et al. Distribution of transforming growth factor-beta isoforms TIF-beta1, TGF-beta2 and TGF-beta 3 and vascular endothelial growth factor in vulvar lichen sclerosus. J Reprod Med 2001; 46: 117–24

    PubMed  CAS  Google Scholar 

  74. Carli P, Moretti S, Spallanzani A, et al. Fibrogenic cytokines in vulvar lichen sclerosus. J Reprod Med 1997; 42: 161–5

    PubMed  CAS  Google Scholar 

  75. Friedrich Jr EG, Kalra PS. Serum levels of sex hormones in vulval lichen sclerosus and the effect of topical testosterone. N Engl J Med 1984; 310: 488–91

    Article  PubMed  Google Scholar 

  76. Kohlberger PD, Joura EA, Bancher D, et al. Evidence of androgen receptor expression in lichen sclerosus: an immunohistochemical study. J Soc Gynecol Investig 1998; 5: 331–3

    Article  PubMed  CAS  Google Scholar 

  77. Clifton MM, Garner I, Kohler S, et al. Immunohistochemical evaluation of androgen receptors in genital and extragenital lichen sclerosus: evidence for loss of androgen receptors in lesional epidermis. J Am Acad Dermatol 1999; 41: 43–6

    Article  PubMed  CAS  Google Scholar 

  78. Hodgins MB, Spike RC, Mackie RM, et al. Immunohistochemisty of steroid receptors in vagina and vulvar skin: evidence for loss of androgen and estrogen receptor in the lesional epidermis of vulvar lichen sclerosus [abstract]. Br J Dermatol 1991; 125: 486

    Google Scholar 

  79. Carlson JA, Murphy M. Androgen receptors and lichen sclerosus. J Am Acad Dermatol 2000; 43: 559–60

    Article  PubMed  CAS  Google Scholar 

  80. Marren P, Cherry C, Day A, et al. Lichen sclerosus: the patient, the hormonal influences and disease impact [abstract]. Br J Dermatol 1995; 21: 133

    Google Scholar 

  81. Zarcone R, Vicinanza G, Bellini P, et al. Drug treatment in vulvar lichen sclerosus. Minerva Ginecolog 1996; 48: 441–4

    CAS  Google Scholar 

  82. Cantwell AR. Histologic observations of variably acid-fast bacteria in scleroderma, morphoea and lichen sclerosus et atrophicus. Int J Dermatol 1984; 23: 45–52

    Article  PubMed  Google Scholar 

  83. Drut RM, Gomez MA, Drut R, et al. Human papillomavirus is present in some cases of childhood penile lichen sclerosus: an in situ hybridization and SP-PCR study. Pediatr Dermatol 1998; 15: 85–90

    Article  PubMed  CAS  Google Scholar 

  84. Rohwedder A, Philips B, Malfetano J, et al. Vulvar malignant melanoma associated with human papillomavirus DNA. Am J Dermatopathol 2002; 24: 230–40

    Article  PubMed  Google Scholar 

  85. Boulinguez S, Bernard P, Lacour JP, et al. Bullous lichen sclerosus with chronic hepatitis C virus infection. Br J Dermatol 1997; 137: 474–5

    Article  PubMed  CAS  Google Scholar 

  86. Ross SA, Sanchez JL, Taboas JO. Spirochetal forms in the dermal lesions of morphea and lichen sclerosus et atrophicus. Am J Dermatopathol 1990; 12: 357–62

    Article  PubMed  CAS  Google Scholar 

  87. Aberer E, Stanek G. Histological evidence for spirochetal origin of morphea and lichen sclerosus et atrophicans. Am J Dermatopathol 1987; 9: 374–9

    Article  PubMed  CAS  Google Scholar 

  88. Weide B, Walz T, Garbe C. Is morphoea caused by Borellia burgdorferi? A review. Br J Dermatol 2000; 142: 636–44

    Article  PubMed  CAS  Google Scholar 

  89. Wallace HJ, Whimster I. Vulval atrophy and leukoplakia. Br J Dermatol 1951; 63: 241–57

    Article  PubMed  CAS  Google Scholar 

  90. Hunt E. Diseases affecting the vulva. London: H Kimpton, 1954

    Google Scholar 

  91. Bottger H, Dittman E. Pruritus, kraurosis vulvae, and vulvakarzinom. Geburtshilfe Frauenheilkd 1957; 12: 1097–109

    Google Scholar 

  92. Suurmond D. Lichen sclerosus et atrophicus of the vulva. Arch Dermatol 1964; 90: 143–53

    Article  PubMed  CAS  Google Scholar 

  93. Gardner HL. Benign diseases of the vulva and vagina. St Louis (MO): CV Mosby Co, 1969

    Google Scholar 

  94. Hart WR, Norris HJ, Helwig EB. Relation of lichen sclerosus et atrophicus of the vulva to development of carcinoma. Obstet Gynecol 1975; 45: 369–77

    PubMed  CAS  Google Scholar 

  95. Kini U. Squamous cell carcinoma of the vulva in association with mixed vulvar dystrophy. Indian J Cancer 1997; 34: 92–5

    PubMed  CAS  Google Scholar 

  96. Carlson JA, Ambros R, Malfetano J, et al. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective: implications for chronic inflammation and sclerosis in development of neoplasia. Hum Pathol 1998; 29: 932–48

    Article  PubMed  CAS  Google Scholar 

  97. Haefner HK, Tate JE, McLachlin CM, et al. Vulvar intraepithelial neoplasia: age, morphological phenotype, papillomavirus DNA, and coexisting invasive carcinoma. Hum Pathol 1995; 26: 147–54

    Article  PubMed  CAS  Google Scholar 

  98. Taussig FJ. Cancer of the vulva: an analysis of 155 cases. Am J Obstet Gynecol 1940; 40: 764–9

    Google Scholar 

  99. Langley II, Hertig A, Smith G. Relation of leukoplakic vulvitis to squamous cell carcinoma of the vulva. Am J Obstet Gynecol 1951; 62: 167–9

    PubMed  CAS  Google Scholar 

  100. Weghaupt K. die Krauosis vulvae und ihre Behandlung mit Elecktrocoagulation. Geburtshilfe Frauenheilkd 1954; 14: 705

    PubMed  CAS  Google Scholar 

  101. Green TH, Ulfelder H, Meigs JV. Epidermoid carcinoma of the vulva: an analysis of 238 cases [paper]. Am J Obstet Gynecol 1958; 75: 834–47

    PubMed  Google Scholar 

  102. Lundwall F. Cancer of the vulva: clinical review [thesis]. Copenhagen: University of Copenhagen, 1961

    Google Scholar 

  103. Buscema J, Stern J, Woodruff JD. The significance of the histologic alterations adjacent to invasive vulvar carcinoma. Am J Obstet Gynecol 1980; 137: 902–9

    PubMed  CAS  Google Scholar 

  104. Zaino RJ, Husseinzadeh N, Nahhas W, et al. Epithelial alterations in proximity to invasive squamous carcinoma of the vulva. Int J Gynecol Pathol 1982; 1: 173–84

    Article  PubMed  CAS  Google Scholar 

  105. Choo YC. Invasive squamous carcinoma of the vulva in young patients. Gynecol Oncol 1982; 13: 158–64

    Article  PubMed  CAS  Google Scholar 

  106. Hacker NF, Berek JS, Lagasse LD, et al. Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet Gynecol 1984; 63: 155–62

    PubMed  CAS  Google Scholar 

  107. Hewitt J. Conditions étiologiques du carcinome invasif d’emblée de la vulve: possibilité d’un traitement prophylactique? J Gynecol Obstet Biol Reprod (Paris) 1984; 13: 297–303

    Google Scholar 

  108. Borgno G, Micheletti L, Barbero M, et al. Epithelial alterations adjacent to 111 vulvar carcinomas. J Reprod Med 1988; 33: 500–2

    PubMed  CAS  Google Scholar 

  109. Leibowitch M, Neill S, Pelisse M, et al. The epithelial changes associated with squamous cell carcinoma of the vulva: a review of the clinical, histological and viral findings in 78 women. Br J Obstet Gynaecol 1990; 97: 1135–9

    Article  PubMed  CAS  Google Scholar 

  110. Toki T, Kurman RJ, Park JS, et al. Probable nonpapillomavirus etiology of squamous cell carcinoma of the vulva in older women: a clinicopathologic study using in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol 1991; 10: 107–25

    Article  PubMed  CAS  Google Scholar 

  111. MacLean AB. Precursors of vulval cancers. Curr Obstet Gynecol 1993; 3: 149–56

    Article  Google Scholar 

  112. Ansink AC, Krul MR, De Weger RA, et al. Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: detection and prognostic significance. Gynecol Oncol 1994; 52: 180–4

    Article  PubMed  CAS  Google Scholar 

  113. Hording U, Junge J, Daugaard S, et al. Vulvar squamous cell carcinoma and papillomaviruses: indications for two different etiologies. Gynecol Oncol 1994; 52: 241–6

    Article  PubMed  CAS  Google Scholar 

  114. Gomez Rueda N, Garcia A, Vighi S, et al. Epithelial alterations adjacent to invasive squamous carcinoma of the vulva. J Reprod Med 1994; 39: 526–30

    PubMed  CAS  Google Scholar 

  115. Sagerman PM, Choi YJ, Hu Y, et al. Human papilloma virus, vulvar dystrophy, and vulvar carcinoma: differential expression of human papillomavirus and vulvar dystrophy in the presence and absence of squamous cell carcinoma of the vulva. Gynecol Oncol 1996; 61: 328–32

    Article  PubMed  CAS  Google Scholar 

  116. Vilmer C, Cavelier-Balloy B, Nogues C, et al. Analysis of alterations adjacent to invasive vulvar carcinoma and their relationship with the associated carcinoma: a study of 67 cases. Eur J Gynaecol Oncol 1998; 19: 25–31

    PubMed  CAS  Google Scholar 

  117. Derrick EK, Ridley CM, Kobza-Black A, et al. A clinical study of 23 cases of female anogenital carcoma. Br J Dermatol 2000; 143: 1217–23

    Article  PubMed  CAS  Google Scholar 

  118. Al-Ghamdi A, Freedman D, Miller D, et al. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. Gynecol Oncol 2002; 84: 94–101

    Article  PubMed  CAS  Google Scholar 

  119. Carli P, Cattaneo A, De Magnis A, et al. Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. Eur J Cancer Prevention 1995; 4: 491–5

    Article  CAS  Google Scholar 

  120. Bart RS, Kopf AW. Tumor conference no 18: squamous-cell carcinoma arising in balanitis xerotica obliterans. J Dermatol Surg Oncol 1978; 4: 556–8

    PubMed  CAS  Google Scholar 

  121. Pride HB, Miller III OF, Tyler WB. Penile squamous cell carcinoma arising from balanitis xerotica obliterans. J Am Acad Dermatol 1993; 29: 469–73

    Article  PubMed  CAS  Google Scholar 

  122. di Paola GR, Rueda-Leverone NG, Belardi MG. Lichen sclerosus of the vulva recurrent after myocutaneous graft: a case report. J Reprod Med 1982; 27: 666–8

    PubMed  Google Scholar 

  123. Thomas RH, McGibbon DH, Munro DD. Basal cell carcinoma of the vulva in association with vulval lichen sclerosus et atrophicus. J R Soc Med 1985; 78 Suppl. 11: 16–8

    PubMed  Google Scholar 

  124. Friedman RJ, Kopf AW, Jones WB. Malignant melanoma in association with lichen sclerosus on the vulva of a 14-year-old. Am J Dermatopathol 1984; 6: 253–6

    PubMed  Google Scholar 

  125. McAdams AJ, Kistner RW. The relationship of chronic vulvar disease, leukoplakia, and carcinoma in situ to carcinoma of the vulva. Cancer 1958; 11: 740–57

    Article  PubMed  Google Scholar 

  126. Egan CA, Bradley RR, Logsdon VK, et al. Vulvar melanoma in childhood. Arch Dermatol 1997; 133: 345–8

    Article  PubMed  CAS  Google Scholar 

  127. Regauer S, Reich O, Beham-Schmid C. Monoclonal gamma-T-cell receptor rearrangement in vulvar lichen sclerosus and squamous cell carcinomas. Am J Pathol 2002; 160: 1035–45

    Article  PubMed  CAS  Google Scholar 

  128. Carlson JA, Amin S, Malfetano J, et al. JS. Concordant p53 and mdm-2 protein expression in vulvar squamous cell carcinoma and adjacent lichen sclerosus. Appl Immunohistochem Mol Morphol 2001; 9: 150–63

    Article  PubMed  CAS  Google Scholar 

  129. Carlson JA, Healy K, Tran TA, et al. Chromosome 17 aneusomy detected by fluorescence in situ hybridization in vulvar squamous cell carcinomas and synchronous vulvar skin. Am J Pathol 2000; 157: 973–83

    Article  PubMed  CAS  Google Scholar 

  130. Pinto AP, Lin MC, Sheets EE, et al. Allelic imbalance in lichen sclerosus, hyperplasia, and intraepithelial neoplasia of the vulva. Gynecol Oncol 2000; 77: 171–6

    Article  PubMed  CAS  Google Scholar 

  131. Rolfe KJ, Crow JC, Benjamin E, et al. Cyclin D1 and retinoblastoma protein in vulvar cancer and adjacent lesions. Int J Gynecol Cancer 2001; 11: 381–6

    Article  PubMed  CAS  Google Scholar 

  132. Tate JE, Mutter GL, Boynton KA, et al. Monoclonal origin of vulvar intraepithelial neoplasia and some vulvar hyperplasias. Am J Pathol 1997; 150: 315–22

    PubMed  CAS  Google Scholar 

  133. Neill SM, Tatnall FM, Cox NH. Guidelines for the management of lichen sclerosus. Br J Dermatol 2002; 147: 640–9

    Article  PubMed  CAS  Google Scholar 

  134. Willliams GA, Richardson AC, Hathcock EE. Topical testosterone in dystrophic diseases of the vulva. Am J Obstet Gynecol 1966; 96: 21–30

    Google Scholar 

  135. Zelle K. Treatment of vulvar dystrophies with topical testosterone propionate. Am J Obstet Gynecol 1971; 109: 570–3

    PubMed  CAS  Google Scholar 

  136. Friedrich EG. Topical testosterone for benign vulvar dystrophy. Obstet Gynecol 1971; 37: 677–86

    PubMed  Google Scholar 

  137. Kaufman RH, Gardner H, Brown D, et al. Vulvar dystrophies: an evaluation. Am J Obstet Gynecol 1974; 120: 363–7

    PubMed  CAS  Google Scholar 

  138. Ayhan A, Urman B, Yuce K, et al. Topical testosterone for lichen sclerosus. Int J Gynaecol Obstet 1989; 30: 253–5

    Article  PubMed  CAS  Google Scholar 

  139. Paslin D. Treatment of lichen sclerosus with topical dihydrotestosterone. Obstet Gynecol 1991; 78: 1046–9

    PubMed  CAS  Google Scholar 

  140. Wright AJ. Testosterone pellet implant therapy for lichen sclerosus. Mo Med 1993; 90: 711–3

    PubMed  CAS  Google Scholar 

  141. Paslin D. Androgens in the topical treatment of lichen sclerosus. Pharmacol Ther 1996; 35: 298–301

    CAS  Google Scholar 

  142. Joura EA, Zeisler H, Bancher-Todesca D, et al. Short-term effects of topical testosterone in vulvar lichen sclerosus. Obstet Gynecol 1997; 89: 297–9

    Article  PubMed  CAS  Google Scholar 

  143. Dalziel KL, Millard PRP, Wojnarowska F. The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol propionate 0.05%) cream. Br J Dermatol 1991; 124: 461–4

    Article  PubMed  CAS  Google Scholar 

  144. Cattaneo A, De Marco A, Sonni L, et al. Clobetasol versus testosterone in the treatment of lichen sclerosus of the vulvar region. Minerva Ginecol 1992; 44: 567–71

    PubMed  CAS  Google Scholar 

  145. Dalziel KL, Wojnarowska F. Long-term control of vulval lichen sclerosus after treatment with a potent topical steroid cream. J Reprod Med 1993; 38: 25–7

    PubMed  CAS  Google Scholar 

  146. Bracco GL, Carli P, Sonni L, et al. Clinical and histologic effects of topical treatments of vulvar lichen sclerosus: a critical evaluation. J Reprod Med 1993; 38: 37–40

    PubMed  CAS  Google Scholar 

  147. Sideri M, Origoni M, Spinaci L, et al. Topical testosterone in the treatment of vulvar lichen sclerosus. Int J Gynaecol Obstet 1994; 46: 53–6

    Article  PubMed  CAS  Google Scholar 

  148. Cattaneo A, Carli P, De Marco A, et al. Testosterone maintenance therapy: effects on vulvar lichen sclerosus treated with clobetasol propionate. J Reprod Med 1996; 41: 99–102

    PubMed  CAS  Google Scholar 

  149. Bornstein J, Heifetz S, Kellner Y, et al. Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus. Am J Obstet Gynecol 1998; 178: 80–4

    Article  PubMed  CAS  Google Scholar 

  150. Sinha P, Sorinola O, Luesley DM. Lichen sclerosus of the vulva: long-term steroid maintenance therapy. J Reprod Med 1999; 44: 621–4

    PubMed  CAS  Google Scholar 

  151. Parker LU, Bergfeld WF. Virilization secondary to topical testosterone. Cleve Clin J Med 1991; 58: 43–6

    PubMed  CAS  Google Scholar 

  152. Punch MR, Ansbacher R. Autogenic masculinization. Am J Obstet Gynecol 1990; 163: 114–6

    PubMed  CAS  Google Scholar 

  153. Ridley CM. Lichen sclerosus. Dermatol Clin 1992; 10: 309–23

    Article  PubMed  CAS  Google Scholar 

  154. Mazdisnian F, Degregorio F, Mazdisnian F, et al. Intralesional injection of triamcinolone in the treatment of lichen sclerosus. J Reprod Med 1999; 44: 332–4

    PubMed  CAS  Google Scholar 

  155. Dutton WA. The use of local injections of triamcinolone into chronic inflammatory lesions of the vulva. J Obstet Gynaecol Br Commonw 1962; 69: 891–2

    Article  Google Scholar 

  156. Neill SM, Ridley CM. Management of anogenital lichen sclerosus. Clin Exp Dermatol 2001; 26: 637–43

    Article  PubMed  CAS  Google Scholar 

  157. Tosti A, Guerra L, Manuzzi P, et al. Contact dermatitis from clobetasol propionate. Contact Dermatitis 1987; 17: 256–7

    Article  PubMed  CAS  Google Scholar 

  158. Torok E, Orley J, Goracz G, et al. Lichen sclerosus et atrophicus in children: clinical and pathological analysis of 33 cases. Mod Probl Paediatr 1975; 17: 262–71

    PubMed  CAS  Google Scholar 

  159. Bohm M, Frieling U, Luger TA, et al. Successful treatment of anogenital lichen sclerosus with topical tacrolimus. Arch Dermatol 2003; 139 (7): 922–4

    Article  PubMed  Google Scholar 

  160. Kunstfeld R, Kirnbauer R, Stingl G, et al. Successful treatment of vulvar lichen sclerosus with topical tacrolimus. Arch Dermatol 2003; 139 (7): 850–2

    Article  PubMed  Google Scholar 

  161. Assmann T, Becker-Wegerich P, Grewe M, et al. Tacrolimus ointment for the treatment of vulvar lichen sclerosus. J Am Acad Dermatol 2003; 48: 935–7

    Article  PubMed  Google Scholar 

  162. Morrison L, Kratochvil III FJ, Gorman A. An open trial of topical tacrolimus for erosive oral lichen planus. J Am Acad Dermatol 2002; 47: 617–20

    Article  PubMed  Google Scholar 

  163. Bergman J, Rico MJ. Tacrolimus clinical studies for atopic dermatitis and other conditions. Semin Cutan Med Surg 2001; 20: 250–9

    Article  PubMed  CAS  Google Scholar 

  164. Nasr IS. Topical tacrolimus in dermatology. Clin Exp Dermatol 2000; 25: 250–4

    Article  PubMed  CAS  Google Scholar 

  165. Wakelin SH, Marren P. Lichen sclerosus in women. Clin Dermatol 1997; 15: 155–69

    Article  PubMed  CAS  Google Scholar 

  166. Parsad D, Saini R. Oral stanozolol in lichen sclerosus et atrophicus. J Am Acad Dermatol 1998; 38: 278–9

    Article  PubMed  CAS  Google Scholar 

  167. Kaufman RH, Faro S, Friedrich E, et al. Benign diseases of the vulva and vagina. St Louis (MO): Mosby Year Book Inc., 1994

    Google Scholar 

  168. Virgili A, Corazza M, Bianchi A, et al. Open study of topical 0.025% tretinoin in the treatment of vulvar lichen sclerosus: one year of therapy. J Reprod Med 1995; 40: 614–8

    PubMed  CAS  Google Scholar 

  169. Penneys N. Treatment of lichen sclerosus with potassium para-aminobenzoate. J Am Acad Dermatol 1984; 10: 1039–42

    Article  PubMed  CAS  Google Scholar 

  170. Everett MA, Coffey CM. Intradermal administration of chloroquine for discoid lupus erythematous and lichen sclerosus et atrophicus. Arch Dermatol 1961; 83: 977–9

    Article  PubMed  CAS  Google Scholar 

  171. NZ Dermatological Society [online]. Available from URL: http://dermnetnz.org/index.html [Accessed 2004 Feb 12]

  172. Vulvar Health lichen sclerosis 2002 [online]. Available from URL: http://www.vulvarhealth.org/LS.html [Accessed 2004 Mar 25]

  173. National Lichen Sclerosus Support Group [online]. Available from URL: http://www.lichensclerosus.org [Accessed 2004 Feb 12]

  174. Wakelin SH, James MP. Extensive lichen sclerosus et atrophicus with bullae and ulceration: improvement with hydroxychloroquine. Clin Exp Dermatol 1994; 19: 332–4

    Article  PubMed  CAS  Google Scholar 

  175. Garcia-Doval I, Peteiro C, Sanchez-Aguilar D, et al. Extensive bullous lichen sclerosus et atrophicus unresponsive to hydroxychloroquine [letter]. Clin Exp Dermatol 1996; 21: 247

    Article  PubMed  CAS  Google Scholar 

  176. Kreuter A, Gambichler T, Sauermann K, et al. Extragenital lichen sclerosus successfully treated with topical calcipotriol: evaluation by in vivo confocal laser scanning microscopy. Br J Dermatol 2002; 146: 332–3

    Article  PubMed  CAS  Google Scholar 

  177. Carli P, Cattaneo A, Taddei G, et al. Topical cyclosporine in the treatment of vulvar lichen sclerosus: clinical, histologic, and immunohistochemical findings. Arch Dermatol 1992; 128: 1548–9

    Article  PubMed  CAS  Google Scholar 

  178. Origoni M, Ferrari D, Rossi M, et al. Topical oxatomide: an alternative approach for the treatment of vulvar lichen sclerosus. Int J Gynaecol Obstet 1996; 55: 259–64

    Article  PubMed  CAS  Google Scholar 

  179. Abramov Y, Elchalal U, Abramov D, et al. Surgical treatment of vulvar lichen sclerosus: a review. Obstet Gynecol Surv 1996; 51: 193–9

    Article  PubMed  CAS  Google Scholar 

  180. Woodruff JD, Baens J. Interpretation of atrophic and hypertrophic alterations in the vulvar epithelium. Am J Obstet Gynecol 1963; 86: 713–23

    PubMed  CAS  Google Scholar 

  181. Paniel BJ. Chapter II: surgical procedures in benign vulval disease. In: Ridly CM, Neill SM, editors. The vulva. Oxford: Blackwell Science, 1999: 288–90

    Google Scholar 

  182. Candiani GB, Mangioni C, Molteni P, et al. Long-term results of surgical treatment of chronic vulvar dystrophies [in Italian]. Ann Ostet Ginecol Med Perinat 1981; 102: 5–9

    PubMed  CAS  Google Scholar 

  183. Rettenmaier MA, Braly P, Roberts W, et al. Treatment of cutaneous vulvar lesions with skinning vulvectomy. J Reprod Med 1985; 30: 478–80

    PubMed  CAS  Google Scholar 

  184. Breech LL, Laufer M. Surgicel in the management of labial and clitoral hood adhesions in adolescents with lichen sclerosus. J Pediatr Adolesc Gynecol 2000; 13: 21–2

    Article  PubMed  CAS  Google Scholar 

  185. Rouzier R, Haddad B, Deyrolle C, et al. Perineoplasty for the treatment of introital stenosis related to vulvar lichen sclerosus. Am J Obstet Gynecol 2002; 186: 49–52

    Article  PubMed  Google Scholar 

  186. Holzgreve W, Schmidt EH. Surgical treatment of therapy refractory pruritus vulvae in lichen sclerosus. Med Welt 1982; 33: 1323–6

    PubMed  CAS  Google Scholar 

  187. Paniel BJ, Truc JB, Robichez B, et al. Vulvoperineoplasty [in French]. Presse Med 1984; 13: 1895–8

    PubMed  CAS  Google Scholar 

  188. van Straalen WR, Hage JJ, Bloemena E, et al. Plastic surgery as a last resort in lichen sclerosus. Ned Tijdschr Geneeskd 1997; 141: 992–8

    PubMed  Google Scholar 

  189. Maessen-Visch MB, Neumann HA. Plastic surgery as a last resort in lichen sclerosus [in Dutch]. Ned Tijdschr Geneeskd 1997; 141: 1583

    PubMed  CAS  Google Scholar 

  190. Ovadia J, Levavi H, Edelstein T. Treatment of pruritus vulvae by means of CO2 laser. Acta Obstet Gynecol Scand 1984; 63: 265–7

    Article  PubMed  CAS  Google Scholar 

  191. Davis AJ, Goldstein DP. Treatment of pediatric lichen sclerosus with CO2 laser. Adolesc Pediatr Gynecol 1989; 2: 103–5

    Google Scholar 

  192. Stuart GC, Nation J, Malliah V, et al. Laser therapy of vulvar lichen sclerosus et atrophicus. Can J Surg 1991; 34: 469–70

    PubMed  CAS  Google Scholar 

  193. Rabinowitz LG. Lichen sclerosus et atrophicus treatment with the 585-nm flashlamp-pumped pulsed dye laser. Arch Dermatol 1993; 129: 381–2

    Article  PubMed  CAS  Google Scholar 

  194. Kartamaa M, Reitamo S. Treatment of lichen sclerosus with carbon dioxide laser vaporization. Br J Dermatol 1997; 136: 356–9

    Article  PubMed  CAS  Google Scholar 

  195. Hillemanns P, Untch M, Prove F, et al. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstet Gynecol 1999; 93: 71–4

    Article  PubMed  CAS  Google Scholar 

  196. Hackenjos K, Schroder W, Schopf E, et al. Therapy of lichen sclerosus et atrophicus vulvae with the CO2 silk touch laser. Hautarzt 2000; 51: 502–4

    Article  PubMed  CAS  Google Scholar 

  197. Zderkiewicz B. Lichen sclerosus et atrophicus hemorrhagicus treated by a new method. Przegl Dermatol 1972; 59: 55–9

    PubMed  CAS  Google Scholar 

  198. August PJ, Milward TM. Cryosurgery in the treatment of lichen sclerosus et atrophicus of the vulva. Br J Dermatol 1980; 103: 667–70

    Article  PubMed  CAS  Google Scholar 

  199. Kreuter A, Gambichler T, Avermaete A, et al. Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: results of a preliminary study. J Am Acad Dermatol 2002; 46: 251–5

    Article  PubMed  Google Scholar 

  200. Haefner HK, Pearlman MD, Barclay ML, et al. Lichen sclerosus in pregnancy: presentation of two cases. J Lower Genital Tract Dis 1999; 3: 260–3

    Google Scholar 

  201. Dalziel KL. Effect of lichen sclerosus on sexual function and parturition. J Reprod Med 1995; 40: 351–4

    PubMed  CAS  Google Scholar 

  202. Schatz M, Hoffman C, Zeiger R, et al. The course and management of asthma and allergic diseases during pregnancy. In: Middleton Jr E, Reed CE, Ellis EF, editors. Allergy: principles and practice. 3rd ed. St Louis (MO): Mosby, 1988: 1124–5

    Google Scholar 

  203. Scott J. Fetal growth retardation associated with maternal administration of immunosuppressive drugs. Am J Obstet Gynecol 1977; 128: 668–76

    PubMed  CAS  Google Scholar 

  204. Katz V, Thorp Jr J, Bowes Jr W. Severe symmetric intrauterine growth retardation associated with the topical use of triamcinolone. Am J Obstet Gynecol 1990; 162: 396–7

    PubMed  CAS  Google Scholar 

  205. Robert E, Scialli A. Topical medications during pregnancy. Reprod Toxicol 1994; 8: 197–202

    Article  PubMed  CAS  Google Scholar 

  206. Laymon CW. Lichen sclerosus et atrophicus in children. Arch Dermatol Syph 1945; 52: 353

    Google Scholar 

  207. Fischer G, Rogers M. Vulvar disease in children: a clinical audit of 130 cases. Pediatr Dermatol 2000; 17: 1–6

    Article  PubMed  CAS  Google Scholar 

  208. Powell JJ, Wojnarowska F. Childhood vulvar lichen sclerosus: an increasingly common problem. J Am Acad Dermatol 2001; 44: 803–6

    Article  PubMed  CAS  Google Scholar 

  209. Berth-Jones J, Graham-Brown RA, Burns DA. Lichen sclerosus et atrophicus: a review of 15 cases in young girls. Clin Exp Dermatol 1991; 16: 14–7

    Article  PubMed  CAS  Google Scholar 

  210. Fivozinsky KB, Laufer M. Vulvar disorders in prepubertal girls. J Reprod Med 1998; 43: 763–73

    PubMed  CAS  Google Scholar 

  211. Gibbon KL, Bewley AP, Salisbury JA. Labial fusion in children: a presenting feature of genital lichen sclerosus. Pediatr Dermatol 1999; 16: 388–91

    Article  PubMed  CAS  Google Scholar 

  212. Warrington SA, de San Lazaro C. Lichen sclerosus et atrophicus and sexual abuse. Arch Dis Child 1996; 75: 512–6

    Article  PubMed  CAS  Google Scholar 

  213. Handfield-Jones SE, Hinde FRJ, Kennedy CTC. Lichen sclerosus et atrophicus in children misdiagnosed as sexual abuse. BMJ 1987; 295: 1404–5

    Article  Google Scholar 

  214. Wood PL, Bevan T. Lesson of the week: child sexual abuse enquiries and unrecognised vulvar lichen sclerosus et atrophicus. BMJ 1999; 319: 899–900

    Article  PubMed  CAS  Google Scholar 

  215. Ridley CM. Genital lichen sclerosus in childhood and adolescence. J R Soc Med 1993; 86: 69–75

    PubMed  CAS  Google Scholar 

  216. Fischer G, Rogers M. Treatment of childhood vulvar lichen sclerosus with potent topical corticosteroid. Pediatr Dermatol 1997; 14: 235–8

    Article  PubMed  CAS  Google Scholar 

  217. Garzon MC, Paller AS. Ultrapotent topical corticosteroid treatment of childhood genital lichen sclerosus. Arch Dermatol 1999; 135: 525–8

    Article  PubMed  CAS  Google Scholar 

  218. Smith YR, Quint EH. Clobetasol propionate in the treatment of premenarchal vulvar lichen sclerosus. Obstet Gynecol 2001; 98: 588–91

    Article  PubMed  CAS  Google Scholar 

  219. Serrano G, Millan F, Fortea J, et al. Topical progesterone as a treatment of choice in genital lichen sclerosus et atrophicus in children. Pediatr Dermatol 1993; 10: 201

    Article  PubMed  CAS  Google Scholar 

  220. Kreuter A, Jansen T, Stucker M, et al. Low-dose ultraviolet-A1 phototherapy for lichen sclerosus et atrophicus. Clin Exp Dermatol 2001; 26: 30–2

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors have provided no information on sources of funding or on conflicts of interest directly relevant to the content of this review.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, The University of Michigan Hospitals Health Systems, Room L4224 Women’s Hospital, 1500 E. Medical Center Drive, Ann Arbor, Michigan, 48109-0276, USA

    Yolanda R. Smith & Hope K. Haefner

Authors
  1. Yolanda R. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hope K. Haefner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yolanda R. Smith.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Smith, Y.R., Haefner, H.K. Vulvar Lichen Sclerosus. Am J Clin Dermatol 5, 105–125 (2004). https://doi.org/10.2165/00128071-200405020-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200405020-00005

Keywords

  • Testosterone
  • Topical Corticosteroid
  • Lichen Planus
  • Alopecia Areata
  • Vulvar Cancer